Package 65219-029-20

{"route": ["INTRACAVITARY", "INTRAVENOUS", "INTRAVESICAL"], "spl_id": "a1ce70f8-1f22-4771-b51a-2e9b12876558", "openfda": {"nui": ["N0000000236", "N0000175558"], "unii": ["905Z5W3GKH"], "rxcui": ["1660004"], "spl_set_id": ["493410f3-0733-4f76-8050-6529d96f2a5b"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (65219-029-20)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "65219-029-20", "marketing_start_date": "20220411"}], "brand_name": "Thiotepa", "product_id": "65219-029_a1ce70f8-1f22-4771-b51a-2e9b12876558", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "65219-029", "generic_name": "Thiotepa", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Thiotepa", "active_ingredients": [{"name": "THIOTEPA", "strength": "100 mg/1"}], "application_number": "ANDA214222", "marketing_category": "ANDA", "marketing_start_date": "20220411", "listing_expiration_date": "20261231"}